Citius Oncology partners with EVERSANA for LYMPHIR drug launch
Go back to Citius Oncology partners with EVERSANA for LYMPHIR drug launch| (NASDAQ: CTOR) | Delayed: 0.88 +0.05 (6.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.83 | 52 Week High | $ | |||
| Open | $0.83 | 52 Week Low | $ | |||
| Day High | $0.91 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $ | |||
| Volume | 92,519 | |||||
| (NASDAQ: CTXR) | Delayed: 0.78 +0.05 (6.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.73 | 52 Week High | $2.50 | |||
| Open | $0.75 | 52 Week Low | $0.40 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $0.00 | |||
| Volume | 308,349 | |||||
